ATNM- sunday phase 1 data for actimab-a. on the daily chart it sits on the 20MA at .25 the 200MA is at .30. High of .40 10/25/19 Volume= 4.7 mill

BCRX- Vol. 5 mill /avg 2 mill -NDA filing due 4Q 2019 to reduce attacks in HAE ppl. sits on the 20MA at 2.50 look for the brake of 3.00 Flag pattern. alert at 2.75 looking for above avg Volume to ride wave to 3.50

NERV- Vol. 289,000 avg. 403,350 Phase 2 for major depressive disorder results 4Q 2019 /no reverse split stock is in an uptrend since low of 4.01 the ceiling is at the 200MA 6.39 Room to 7.75 high of 6.53

ADMS Vol 485,949 Avg 518,596 . Phase 3 data 4Q 2019 Multiple Sclerosis. stock split -1/18/2000 3for2. the 200MA is at 7.04 20MA is at 5.73 uptrending but is overextended 

OBSV- Vol. 408,200 Avg 203,131 phase 3 data due Monday Dec.9/2019 PRIMROSE 2 uterine fibroids GAp down 11/4 Low 2.37 now in up trend in the month of dec. consolidating at 4.57 a brake of 6.00 leave room to 8.00 to fill the gap. current price 5.65 (Alert set at 5.90)

CALA-Vol381k avg 424k  Phase 2 dec 9 at 7:30 am EST Telaglenastat (CB-839)reverse split 2 for 7/17/1996 Stock is  in an trend with the flag pattern resting on the 200 day MA 428 high of 6.90 current price is a 5.10